Unknown

Dataset Information

0

Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia.


ABSTRACT: BACKGROUND:End-induction minimal residual disease (MRD) is the strongest predictor of relapse in paediatric acute lymphoblastic leukaemia (ALL), but an understanding of the biological pathways underlying early treatment response remains elusive. We hypothesized that metabolomic profiling of diagnostic bone marrow plasma could provide insights into the underlying biology of early treatment response and inform treatment strategies for high-risk patients. METHODS:We performed global metabolomic profiling of samples from discovery (N?=?93) and replication (N?=?62) cohorts treated at Texas Children's Hospital. Next, we tested the cytotoxicity of drugs targeting central carbon metabolism in cell lines and patient-derived xenograft (PDX) cells. FINDINGS:Metabolite set enrichment analysis identified altered central carbon and amino acid metabolism in MRD-positive patients from both cohorts at a 5% false discovery rate. Metabolites from these pathways were used as inputs for unsupervised hierarchical clustering. Two distinct clusters were identified, which were independently associated with MRD after adjustment for immunophenotype, cytogenetics, and NCI risk group. Three nicotinamide phosphoribosyltransferase (NAMPT) inhibitors, which reduce glycolytic/TCA cycle activities, demonstrated nanomolar-range cytotoxicity in B- and T-ALL cell lines and PDX cells. INTERPRETATION:This study provides new insights into the role of central carbon metabolism in early treatment response and as a potential targetable pathway in high-risk disease. FUNDING:American Society of Hematology; Baylor College of Medicine Department of Paediatrics; Cancer Prevention and Research Institute of Texas; the Lynch family; St. Baldrick's Foundation with support from the Micaela's Army Foundation; United States National Institutes of Health.

SUBMITTER: Schraw JM 

PROVIDER: S-EPMC6838385 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia.

Schraw Jeremy M JM   Junco Jacob J JJ   Brown Austin L AL   Scheurer Michael E ME   Rabin Karen R KR   Lupo Philip J PJ  

EBioMedicine 20191017


<h4>Background</h4>End-induction minimal residual disease (MRD) is the strongest predictor of relapse in paediatric acute lymphoblastic leukaemia (ALL), but an understanding of the biological pathways underlying early treatment response remains elusive. We hypothesized that metabolomic profiling of diagnostic bone marrow plasma could provide insights into the underlying biology of early treatment response and inform treatment strategies for high-risk patients.<h4>Methods</h4>We performed global  ...[more]

Similar Datasets

| S-EPMC4693965 | biostudies-literature
| S-EPMC4808717 | biostudies-literature
| S-EPMC6854698 | biostudies-literature
| S-EPMC4163748 | biostudies-literature
| S-EPMC4612585 | biostudies-literature
| S-EPMC5626434 | biostudies-literature
| S-EPMC5352064 | biostudies-literature
| S-EPMC3171799 | biostudies-literature
| S-EPMC3290726 | biostudies-literature
| S-EPMC4486228 | biostudies-literature